Faculty

32 1a 2a

61 16

Phillip Scott, Ph.D.

7 4 1 23

1f Graduate Group Affiliations 8

Immunology
Cell and Molecular Biology

46 Contact information
3f

310 Hill Pavilion
25 School of Veterinary Medicine
43 380 South University Avenue
Philadelphia, PA 19104-4539

3a Office: (215) 898-1602; 898-9793
34 Fax: (215) 746-2294
24

Email:
pscott@vet.upenn.edu

4 3 3 1d

18 Publications
23

147 6f

26 Search PubMed for articles c

3 2 4 b 1f

13 Education:
21 7 BS 14 (Biology) c
3c Villanova University, Villanova, PA, 1975.
21 a Ph.D. 19 (Parasitology) c
45 University of Pennsylvania, Philadelphia, PA, 1980.
c

3 27

Links
193 Search PubMed for articles
87 Immunology graduate group
2e Cell and Molecular Biology Graduate Group
c

5 3 3 92 Permanent link
2 29

b6 > Perelman School of Medicine > Faculty > Details a

1e 1d

Description of Research Expertise

2b Research Interests
34 T cells and cytokines in infectious disease
23 Host-pathogen interactions
29 Development of Th1 and Th2 cells
17 Memory T cells
8
5e Key words: parasites, Leishmania, T cells, Th1 cells, Th2 cells, memory T cells
8
40b

Dr. Scott's current research is focused on understanding the development, regulation and maintenance of CD4+ and CD8+ T cells in order to design new vaccines and immunotherapies for infectious diseases. The laboratory primarily focuses on experimental murine infections with the protozoan parasite, Leishmania, which provides a well-characterized model of T helper cell differentiation. The use of IL-12 as an adjuvant to promote Th1 cell development, as well as the ability of combined drug and IL-12 therapy to promote a Th2 to Th1 switch, was first shown in this laboratory. Both findings have implications for the control and treatment of infectious diseases, autoimmunity and allergy. While much has been learned about the development of Th1 cells, our understanding of how to maintain Th1 responses is limited. This is highlighted by the fact that there is no vaccine for human leishmaniasis.

347

Dr. Scott's laboratory is investigating the role of cytokines, antigen-dose, CD8+ T cells, regulatory T cells and antigen persistence in the development of immunologic memory. Another major interest in this laboratory is to better understand how different species of Leishmania interact with the host immune system, in order to develop new treatments for chronic leishmaniasis. For example, in contrast to L. major infections, infections with L. mexicana fail to resolve in C57BL/6 mice, and the lab has linked this phenotype to a defect in dendritic cell activation following infection. On the other hand, infections with L. braziliensis resolve in BALB/c mice, which are susceptible to both L. major and L. mexicana, and studies are underway to elucidate the factors that promote lesion resolution with this parasite.

8
2c5 Most recently, the Scott lab has begun studies in Brazil, funded by a NIH International Collaborations in Infectious Disease Research (ICIDR) grant, to understand the pathogenesis of L. braziliensis in patients. L. braziliensis can cause disfiguring chronic disease, in spite of the development of a strong immune response and control of the parasites. Thus, the disease is primarily due to immunopathology, including the production of high levels of TNF-α. One type of monocyte (termed proinflammatory monocytes) is known to produce high levels of TNF-α, and this subset is expanded in L. braziliensis patients. The Scott lab is looking at the how these monocytes are regulated during infection.
26 29

Selected Publications

158 Carvalho Lucas P, Petritus Patricia M, Trochtenberg Alyssa L, Zaph Colby, Hill David A, Artis David, Scott Phillip: Lymph node hypertrophy following Leishmania major infection is dependent on TLR9. Journal of immunology (Baltimore, Md. : 1950) 188(3): 1394-401, Feb 2012.

d1 Kaye Paul, Scott Phillip: Leishmaniasis: complexity at the host-pathogen interface. Nature reviews. Microbiology 9(8): 604-15, Aug 2011.

bf Kaye, P., and P. Scott: Leishmaniasis: complexity at the host-pathogen interface. Nat Rev Microbiol 9: 604-615, 2011.

da Colpitts, S. L., and P. Scott: The early generation of a heterogeneous CD4+ T cell response to Leishmania major. J Immunol 185: 2416-2423, 2010.

141 Colpitts, S. L., N. M. Dalton, and P. Scott.: IL-7 receptor expression provides the potential for long-term survival of both CD62Lhigh central memory T cells and Th1 effector cells during Leishmania major infection. J Immunol 182: 5702-5711, 2009.

14b Ng, L. G., A. Hsu, M. A. Mandell, B. Roediger, C. Hoeller, P. Mrass, A. Iparraguirre, L. L. Cavanagh, J. A. Triccas, S. M. Beverley, P. Scott, and W. Weninger.: Migratory dermal dendritic cells act as rapid sensors of protozoan parasites. PLoS Pathog 2008.

172 Carvalho, L. P., E. J. Pearce, and P. Scott. : Functional dichotomy of dendritic cells following interaction with Leishmania braziliensis: infected cells produce high levels of TNF-alpha, whereas bystander dendritic cells are activated to promote T cell responses. J Immunol 181: 6473-6480. 2008.

11d Pakpour, N., Zaph, C., and P. Scott: The central memory CD4+ T cell population generated during Leishmania major infection requires IL-12 to produce IFN-gamma. Journal of Immunology 180(12): 8299-8305, June 2008.

14a Uzonna, Jude E. Joyce, Karen L. Scott, Phillip.: Low dose Leishmania major promotes a transient T helper cell type 2 response that is down-regulated by interferon gamma-producing CD8+ T cells. Journal of Experimental Medicine 199(11): 1559-66, Jun 7 2004.

133 Zaph, Colby. Uzonna, Jude. Beverley, Stephen M. Scott, Phillip.: Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites.[see comment]. Nature Medicine 10(10): 1104-10, Oct 2004.

2c

7 1d

2c back to top
26 Last updated: 02/21/2022
34 The Trustees of the University of Pennsylvania c

1 49 2 2 1a 32 34